Clinical recognition of frontotemporal dementia with right anterior temporal predominance: A multicenter retrospective cohort study
- PMID: 38982845
- PMCID: PMC11350044
- DOI: 10.1002/alz.14076
Clinical recognition of frontotemporal dementia with right anterior temporal predominance: A multicenter retrospective cohort study
Abstract
Introduction: Although frontotemporal dementia (FTD) with right anterior temporal lobe (RATL) predominance has been recognized, a uniform description of the syndrome is still missing. This multicenter study aims to establish a cohesive clinical phenotype.
Methods: Retrospective clinical data from 18 centers across 12 countries yielded 360 FTD patients with predominant RATL atrophy through initial neuroimaging assessments.
Results: Common symptoms included mental rigidity/preoccupations (78%), disinhibition/socially inappropriate behavior (74%), naming/word-finding difficulties (70%), memory deficits (67%), apathy (65%), loss of empathy (65%), and face-recognition deficits (60%). Real-life examples unveiled impairments regarding landmarks, smells, sounds, tastes, and bodily sensations (74%). Cognitive test scores indicated deficits in emotion, people, social interactions, and visual semantics however, lacked objective assessments for mental rigidity and preoccupations.
Discussion: This study cumulates the largest RATL cohort unveiling unique RATL symptoms subdued in prior diagnostic guidelines. Our novel approach, combining real-life examples with cognitive tests, offers clinicians a comprehensive toolkit for managing these patients.
Highlights: This project is the first international collaboration and largest reported cohort. Further efforts are warranted for precise nomenclature reflecting neural mechanisms. Our results will serve as a clinical guideline for early and accurate diagnoses.
Keywords: emotion recognition; frontotemporal dementia; frontotemporal lobar degeneration; right anterior temporal lobe; semantic dementia; social cognition.
© 2024 The Author(s). Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Conflict of interest statement
The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. Oskar Hansson has acquired research support (for the institution) from ADx, AVID Radiopharmaceuticals, Biogen, Eli Lilly, Eisai, Fujirebio, GE Healthcare, Pfizer, and Roche. In the past 2 years, he has received consultancy/speaker fees from AC Immune, Amylyx, Alzpath, BioArctic, Biogen, Cerveau, Eisai, Eli Lilly, Fujirebio, Merck, Novartis, Novo Nordisk, Roche, Sanofi, and Siemens. Other authors declare no competing interest. Author disclosures are available in the supporting information.
Figures


References
-
- Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546‐1554. - PubMed
-
- Kumfor F, Landin‐Romero R, Devenney E, et al. On the right side? A longitudinal study of left‐ versus right‐lateralized semantic dementia. Brain J Neurol. 2016;139:986‐998. - PubMed
Publication types
MeSH terms
Grants and funding
- AF-980907/Swedish Alzheimer Foundation
- Sequoia Fund
- Fondation France Alzheimer
- 2022-00775/Swedish Research Council
- R01 AG052496/AG/NIA NIH HHS/United States
- CNPq
- NIHR UCLH Biomedical Research Centre
- R01 AG037491/AG/NIA NIH HHS/United States
- R21 NS094684/NS/NINDS NIH HHS/United States
- K24 DC015544/DC/NIDCD NIH HHS/United States
- IDN/21/010/KU Leuven
- RF1 AG029577/AG/NIA NIH HHS/United States
- R01-AG37491/Josephs and Whitwell
- K23 AG063900/AG/NIA NIH HHS/United States
- Fondation Planiol
- R01 AG029577/AG/NIA NIH HHS/United States
- ALZS_/Alzheimer's Society/United Kingdom
- K23 AG063900-01A1/Pressman
- Lund University
- RF1-AG029577/The National Brain Appeal
- 2017-0383/Knut and Alice Wallenberg Foundation
- P01 AG019724/AG/NIA NIH HHS/United States
- AACSF-22-849085/ALZ/Alzheimer's Association/United States
- RF1 NS050915/NS/NINDS NIH HHS/United States
- R01 DC010367/DC/NIDCD NIH HHS/United States
- R01 NS050915/NS/NINDS NIH HHS/United States
- R21-NS94684/Josephs and Whitwell
- C24/18/095/KU Leuven
- R01-DC010367/Josephs and Whitwell
- Royal National Institute for Deaf People
- Alzheimer's Research UK
- RF1-AG029577/Rankin
- 2022-Projekt0080/Swedish Federal Government